best time to start tirzepatide Take Zepbound® Tirzepatide Dosage Guide

Overview of Clinical Trial in Pediatric Patients WEGOVY injection was evaluated to reduce excess body weight in pediatric patients aged 12 years of age and older with obesity in a 68-week, double-blind, randomized, parallel group, placebo-controlled, multi-center trial in 201 pubertal pediatric patients aged 12 years and older with BMI corresponding to 95th percentile standardized for age and sex (Study 10) (NCT#04102189)

They concluded in the pooled analysis of 5,325 randomized and exposed individuals that rates of depression (2.1 vs 2.1 events/100 person-years) through adverse event reporting were similarly low in liraglutide and placebo groups

For comparisons including baseline effects, baseline was defined as the mean of the last 3 days prior to the beginning of injection

The titration schedule is designed to gradually increase receptor engagement whilst minimising side effects